Literature DB >> 11761470

Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord.

M K Olsen1, S L Roberds, B R Ellerbrock, T J Fleck, D K McKinley, M E Gurney.   

Abstract

Mutations of copper,zinc-superoxide dismutase (cu,zn SOD) are found in patients with a familial form of amyotrophic lateral sclerosis. When expressed in transgenic mice, mutant human cu,zn SOD causes progressive loss of motor neurons with consequent paralysis and death. Expression profiling of gene expression in SOD1-G93A transgenic mouse spinal cords indicates extensive glial activation coincident with the onset of paralysis at 3 months of age. This is followed by activation of genes involved in metal ion regulation (metallothionein-I, metallothionein-III, ferritin-H, and ferritin-L) at 4 months of age just prior to end-stage disease, perhaps as an adaptive response to the mitochondrial destruction caused by the mutant protein. Induction of ferritin-H and -L gene expression may also limit iron catalyzed hydroxyl radical formation and consequent oxidative damage to lipids, proteins, and nucleic acids. Thus, glial activation and adaptive responses to metal ion dysregulation are features of disease in this transgenic model of familial amyotrophic lateral sclerosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11761470     DOI: 10.1002/ana.1252

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  38 in total

1.  C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice.

Authors:  Christian S Lobsiger; Severine Boillée; Christine Pozniak; Amir M Khan; Melissa McAlonis-Downes; Joseph W Lewcock; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-29       Impact factor: 11.205

2.  Serum ferritin is a candidate biomarker of disease aggravation in amyotrophic lateral sclerosis.

Authors:  Jixu Yu; Nian Wang; Faying Qi; Xianjun Wang; Qiyi Zhu; Yucheng Lu; Huiling Zhang; Fengyuan Che; Wei Li
Journal:  Biomed Rep       Date:  2018-08-02

3.  Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model.

Authors:  Rengang Wang; Bo Yang; Dongxian Zhang
Journal:  Glia       Date:  2011-03-28       Impact factor: 7.452

Review 4.  Iron and Neurodegeneration: Is Ferritinophagy the Link?

Authors:  Giorgio Biasiotto; Diego Di Lorenzo; Silvana Archetti; Isabella Zanella
Journal:  Mol Neurobiol       Date:  2015-10-14       Impact factor: 5.590

5.  Full-length apolipoprotein E protects against the neurotoxicity of an apoE-related peptide.

Authors:  K A Crutcher; H N Lilley; S R Anthony; W Zhou; V Narayanaswami
Journal:  Brain Res       Date:  2009-10-21       Impact factor: 3.252

6.  BRI2 interacts with BACE1 and regulates its cellular levels by promoting its degradation and reducing its mRNA levels.

Authors:  Maria Tsachaki; Angeliki Fotinopoulou; Nefeli Slavi; Vasiliki Zarkou; Jorge Ghiso; Spiros Efthimiopoulos
Journal:  Curr Alzheimer Res       Date:  2013-06       Impact factor: 3.498

Review 7.  Current and future directions in genomics of amyotrophic lateral sclerosis.

Authors:  John Ravits; Bryan J Traynor
Journal:  Phys Med Rehabil Clin N Am       Date:  2008-08       Impact factor: 1.784

8.  Transcriptional profile of primary astrocytes expressing ALS-linked mutant SOD1.

Authors:  Marcelo R Vargas; Mariana Pehar; Pablo J Díaz-Amarilla; Joseph S Beckman; Luis Barbeito
Journal:  J Neurosci Res       Date:  2008-12       Impact factor: 4.164

9.  Magnetic resonance microscopy and immunohistochemistry of the CNS of the mutant SOD murine model of ALS reveals widespread neural deficits.

Authors:  M S Petrik; J M B Wilson; S C Grant; S J Blackband; R C Tabata; X Shan; C Krieger; C A Shaw
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

10.  Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis.

Authors:  Muddasir Qureshi; Robert H Brown; Jack T Rogers; Merit E Cudkowicz
Journal:  Open Neurol J       Date:  2008-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.